Stock News & Analysis

Investors will quickly figure out that a potential stock needs to clear two primary hurdles.

This stock has paid off handsomely for the past seven years.

Despite trading 24% off its peak, this business has been a huge moneymaker for its early shareholders.

The manufacturer of advanced semiconductor and fiber lasers reported a notable insider stock sale.

Both companies develop next-generation nuclear reactors, but one stock may offer greater upside.

The $14 billion buyback is a big deal that was tucked away in a superb earnings report.

The customer relationship management platform provider reported a notable insider sale amid a decline in share price over the past year.

A double by 2031 would need roughly half the growth the broker is already posting.

Hyperliquid is up big in 2026. But how much longer can it sustain this momentum?

A bear market is coming eventually, and the smartest investors are already preparing.

Swing upon the stars with this under-the-radar space stock.

SpaceX's Colossus 2 supercomputer could double its number of Nvidia GPUs by year-end.

BigBear.ai's revenue has declined sharply while SoundHound AI's accelerated, widening the gap to $25.2 million in the latest quarter.

Why would a cloud company in the middle of a huge build-out charge more for the chips anybody can rent by the hour?

Salesforce commands a 6x revenue advantage, but Palantir's growth rate is nearly triple — a divergence that will determine which thesis wins.

A lot of anticipated growth is already baked into the current stock price.

A 64-year streak of increasing the payout makes this a top dividend stock.

Bristol Myers Squibb raised its 2026 sales outlook in July, while Novo Nordisk expects its sales to be flat at best this year, yet Bristol Myers Squibb trades at the lower earnings multiple.

This is one of the highest-quality businesses in the conglomerate's portfolio.

The cloud unit is growing faster than it has in years. Why are the shares cheaper than they were in August?